General Information of Drug Off-Target (DOT) (ID: OT4RULP5)

DOT Name Thioredoxin domain-containing protein 3 (NME8)
Synonyms 3'-5' exonuclease NME8; EC 3.1.-.-; NM23-H8; NME/NM23 family member 8; Spermatid-specific thioredoxin-2; Sptrx-2
Gene Name NME8
Related Disease
Alzheimer disease ( )
Knee osteoarthritis ( )
Male infertility ( )
Osteoarthritis ( )
Primary ciliary dyskinesia ( )
Periodontitis ( )
Primary ciliary dyskinesia 6 ( )
UniProt ID
TXND3_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
3.1.-.-
Pfam ID
PF00334 ; PF00085
Sequence
MASKKREVQLQTVINNQSLWDEMLQNKGLTVIDVYQAWCGPCRAMQPLFRKLKNELNEDE
ILHFAVAEADNIVTLQPFRDKCEPVFLFSVNGKIIEKIQGANAPLVNKKVINLIDEERKI
AAGEMARPQYPEIPLVDSDSEVSEESPCESVQELYSIAIIKPDAVISKKVLEIKRKITKA
GFIIEAEHKTVLTEEQVVNFYSRIADQCDFEEFVSFMTSGLSYILVVSQGSKHNPPSEET
EPQTDTEPNERSEDQPEVEAQVTPGMMKNKQDSLQEYLERQHLAQLCDIEEDAANVAKFM
DAFFPDFKKMKSMKLEKTLALLRPNLFHERKDDVLRIIKDEDFKILEQRQVVLSEKEAQA
LCKEYENEDYFNKLIENMTSGPSLALVLLRDNGLQYWKQLLGPRTVEEAIEYFPESLCAQ
FAMDSLPVNQLYGSDSLETAEREIQHFFPLQSTLGLIKPHATSEQREQILKIVKEAGFDL
TQVKKMFLTPEQIEKIYPKVTGKDFYKDLLEMLSVGPSMVMILTKWNAVAEWRRLMGPTD
PEEAKLLSPDSIRAQFGISKLKNIVHGASNAYEAKEVVNRLFEDPEEN
Function
Probably required during the final stages of sperm tail maturation in the testis and/or epididymis, where extensive disulfide bonding of fibrous sheath (FS) proteins occurs. In vitro, it has neither nucleoside diphosphate kinase (NDPK) activity nor reducing activity on disulfide bonds. Exhibits a 3'-5' exonuclease activity with a preference for single-stranded DNA, suggesting roles in DNA proofreading and repair.
Tissue Specificity Testis-specific. Expressed only in primary spermatocytes and round spermatids.

Molecular Interaction Atlas (MIA) of This DOT

7 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Alzheimer disease DISF8S70 Strong Genetic Variation [1]
Knee osteoarthritis DISLSNBJ Strong Genetic Variation [2]
Male infertility DISY3YZZ Strong Biomarker [3]
Osteoarthritis DIS05URM Strong Biomarker [4]
Primary ciliary dyskinesia DISOBC7V Supportive Autosomal dominant [5]
Periodontitis DISI9JOI Limited Genetic Variation [6]
Primary ciliary dyskinesia 6 DISZ7307 Limited Autosomal recessive [7]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
9 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Thioredoxin domain-containing protein 3 (NME8). [8]
Tretinoin DM49DUI Approved Tretinoin increases the expression of Thioredoxin domain-containing protein 3 (NME8). [9]
Vorinostat DMWMPD4 Approved Vorinostat increases the expression of Thioredoxin domain-containing protein 3 (NME8). [10]
Panobinostat DM58WKG Approved Panobinostat increases the expression of Thioredoxin domain-containing protein 3 (NME8). [10]
SNDX-275 DMH7W9X Phase 3 SNDX-275 increases the expression of Thioredoxin domain-containing protein 3 (NME8). [11]
Amiodarone DMUTEX3 Phase 2/3 Trial Amiodarone increases the expression of Thioredoxin domain-containing protein 3 (NME8). [12]
Belinostat DM6OC53 Phase 2 Belinostat increases the expression of Thioredoxin domain-containing protein 3 (NME8). [10]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 decreases the expression of Thioredoxin domain-containing protein 3 (NME8). [14]
Trichostatin A DM9C8NX Investigative Trichostatin A increases the expression of Thioredoxin domain-containing protein 3 (NME8). [15]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene affects the methylation of Thioredoxin domain-containing protein 3 (NME8). [13]
------------------------------------------------------------------------------------

References

1 Association and interaction effects of Alzheimer's disease-associated genes and lifestyle on cognitive aging in older adults in a Taiwanese population.Oncotarget. 2017 Apr 11;8(15):24077-24087. doi: 10.18632/oncotarget.15269.
2 Association of single-nucleotide polymorphisms in RHOB and TXNDC3 with knee osteoarthritis susceptibility: two case-control studies in East Asian populations and a meta-analysis.Arthritis Res Ther. 2008;10(3):R54. doi: 10.1186/ar2423. Epub 2008 May 10.
3 A common variant in combination with a nonsense mutation in a member of the thioredoxin family causes primary ciliary dyskinesia. Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3336-41. doi: 10.1073/pnas.0611405104. Epub 2007 Feb 20.
4 Genetic association analysis of RHOB and TXNDC3 in osteoarthritis.Am J Hum Genet. 2007 Feb;80(2):383-6; author reply 386-7. doi: 10.1086/511443.
5 Primary Ciliary Dyskinesia. 2007 Jan 24 [updated 2019 Dec 5]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews(?) [Internet]. Seattle (WA): University of Washington, Seattle; 1993C2024.
6 A genome-wide association study of periodontitis in a Japanese population.J Dent Res. 2015 Apr;94(4):555-61. doi: 10.1177/0022034515570315. Epub 2015 Feb 11.
7 Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6.
8 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
9 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
10 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
11 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
12 Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. PLoS One. 2009 Sep 23;4(9):e7155.
13 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
14 BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia. Blood. 2012 Oct 4;120(14):2843-52.
15 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.